Pharmacodynamic Interaction of Areca catechu with Gliclazide in Wistar Rats

Simple item page
dc.contributor.authorAl-Omran, Suliman Abdullahen_US
dc.contributor.authorS, Dharmashreeen_US
dc.contributor.authorKV, Anil Kumaren_US
dc.contributor.authorNagaraja, Sreeharshaen_US
dc.date.accessioned2024-12-02T09:58:56Z
dc.date.available2024-12-02T09:58:56Z
dc.date.issued2024-01
dc.description.abstractBackground and Purpose: In alloxan-induced diabetic rats, this study sought to evaluate the hypoglycemic potential of the hydroalcoholic seed extract of Areca catechu, also referred to as areca nut, both as a stand-alone treatment and in combination with the diabetic drug gliclazide. Materials and Methods: The hot percolation method was used to produce the hydroalcoholic seed extract of A. catechu. Rats were given alloxan monohydrate and developed type II diabetes. The hydroalcoholic seed extract of A. catechu (1000 mg/kg p.o.) alone or in different combinations of gliclazide (25 mg/kg p.o.) and A. catechu extract (250, 500, and 1000 mg/kg p.o.) were administered to the six diabetic rats. Body weights and blood glucose levels were measured on days 7, 14, 21, and 28 of the treatment. On the 28th day, the kidney, liver, and pancreas underwent histological investigations in addition to an oral glucose tolerance test (OGTT). Results: Blood glucose levels were significantly lowered upon administration of A. catechu’s hydroalcoholic seed extract, both alone and in conjunction with gliclazide. Comparing the diabetic control group to the A. catechu extract-treated group, histopathological examinations showed that high amounts of the extract, either by itself or in conjunction with gliclazide, caused the active proliferation of pancreatic beta cells, protecting against damage to the liver and kidneys. Conclusion: The hydroalcoholic seed extract of A. catechu showed promise as a monotherapy for controlling blood glucose levels, and as a co-administer for gliclazide, it showed signs of hypoglycemia. These results indicate A. catechu’s possible therapeutic benefit as an adjuvant diabetic treatment. To investigate the underlying mechanisms of action and evaluate its safety and effectiveness in clinical settings, more study is necessary.en_US
dc.identifier.affiliationsDepartment of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al Ahsa, Eastern Province, Saudi Arabiaen_US
dc.identifier.affiliationsDepartment of Pharmacology, Visveswarapura Institute of Pharmaceutical Sciences, Bengaluru, Karnataka, Indiaen_US
dc.identifier.affiliationsDepartment of Pharmacology, Visveswarapura Institute of Pharmaceutical Sciences, Bengaluru, Karnataka, Indiaen_US
dc.identifier.affiliationsDepartment of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al Ahsa, Eastern Province, Saudi Arabia; Department of Pharmaceutics, Vidya Siri College of Pharma, Bangalore, Karnataka, Indiaen_US
dc.identifier.citationAl-Omran Suliman Abdullah, S Dharmashree, KV Anil Kumar, Nagaraja Sreeharsha . Pharmacodynamic Interaction of Areca catechu with Gliclazide in Wistar Rats. Journal of Pharmacology and Pharmacotherapeutics. 2024 Jan; 15(1): 69–77en_US
dc.identifier.issn0976-500X
dc.identifier.issn0976-5018
dc.identifier.placeIndiaen_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/239311
dc.languageenen_US
dc.publisherSage Publications India Pvt. Ltd.en_US
dc.relation.issuenumber1en_US
dc.relation.volume15en_US
dc.source.urihttps://doi.org/10.1177/0976500X241231365en_US
dc.subjectPharmacodynamic interactionsen_US
dc.subjectAreca catechuen_US
dc.subjectGliclazideen_US
dc.subjectpolyphenolsen_US
dc.titlePharmacodynamic Interaction of Areca catechu with Gliclazide in Wistar Ratsen_US
dc.typeJournal Articleen_US
Files
Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
jpp2024v15n1p69.pdf
Size:
6.28 MB
Format:
Adobe Portable Document Format
Download
Collections
Journal of Pharmacology and Pharmacotherapeutics